Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism with Intravenous Nonviral Gene Therapy and a Brain-Specific Promoter-Reference-Cited by-同舟云学术

Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism with Intravenous Nonviral Gene Therapy and a Brain-Specific Promoter

Published:2004-04 Issue:4 Volume:15 Page:339-350
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Zhang Yun¹,Schlachetzki Felix²,Zhang Yu-Feng¹,Boado Ruben J.¹,Pardridge William M.¹

Affiliation:

1. Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90024

2. Department of Neurology, University of Regensburg, 93053 Regensburg, Germany

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303404322959498

Reference38 articles.

1. Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants

2. Ten nucleotide cis element in the 3′-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization

3. Selective expression of the large neutral amino acid transporter at the blood-brain barrier

4. GFAP promoter directs astrocyte-specific expression in transgenic mice

5. A Neural-Specific Hypomethylated Domain in the 5' Flanking Region of the Glial Fibrillary Acidic Protein Gene

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes;Molecular Neurobiology;2024-06-10

2. Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review;Drug Delivery and Translational Research;2024-04-08

3. Targeted Therapy for Neurological Disorders Using Nanomaterial-Based Drug Delivery Vehicle;Smart Nanomaterials Technology;2024

4. Treatment of Parkinson’s disease with biologics that penetrate the blood–brain barrier via receptor-mediated transport;Frontiers in Aging Neuroscience;2023-11-13

5. Brain gene therapy with Trojan horse lipid nanoparticles;Trends in Molecular Medicine;2023-05